Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

0

Number of overlapping holdings

0.0%

% of MEDX's 32 holdings also in PPH

nan%

% of PPH's 26 holdings also in MEDX

Overlap by Weight
Sector Drift (MEDX minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PPH
Overlap

Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PPH
ELI LILLY & CO 11.7%
ABBVIE INC 6.2%
NOVARTIS AG-ADR 5.5%
AMGEN INC 5.2%
BRISTOL-MYERS SQUIBB CO 5.1%
JOHNSON & JOHNSON 5.1%
ASTRAZENECA PLC-SPONS ADR 4.7%
PFIZER INC 4.6%
CRISPR THERAPEUTICS AG 4.4%
BIOGEN IDEC INC 4.2%
MEDX Underweight Relative to PPH
2SEVENTY BIO, INC. 0.2%
VIATRIS, INC. 0.2%
ALLOGENE THERAPEUTICS, INC. 0.3%
GE HEALTHCARE TECHNOLOGIES INC. 0.4%
VANDA PHARMACEUTICALS INC 0.5%
GALECTIN THERAPEUTICS INC 0.6%
LANTERN PHARMA, INC. 0.7%
REPLIMUNE GROUP, INC. 0.9%
INTELLIA THERAPEUTICS, INC. 1.6%
EDITAS MEDICINE, INC. 1.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY